Sonablate Launches SONA FUSION Global Registry for Focal Therapy

Sonablate has launched the SONA FUSION Registry, an initiative aimed at collecting real-world evidence for treatment outcomes of prostate cancer and benign prostatic hyperplasia (BPH) using High-Intensity Focused Ultrasound (HIFU). This global registry, expected to include over 5,000 patients across multiple countries, aims to address the lack of standardized long-term data and support the evolving landscape of personalized prostate care. It will help unify evidence collection, inform treatment practices, and set benchmarks for future clinical guidelines in the field.